Herbosa Hit with New Raps over Alleged P1.5B Expired Meds, Vaccines | INQToday
Why It Matters
The case highlights systemic weaknesses in the Philippines’ health‑supply chain, risking vaccine shortages and exposing officials to legal and reputational fallout.
Key Takeaways
- •Health Secretary Herbosa faces new criminal complaints over expired stock
- •Alleged P1.5 billion in dead medicines and vaccines uncovered
- •16 DOH officials accused of misconduct and dishonesty
- •Complaint seeks preventive suspension to halt further abuse
- •Undelivered vaccines worth P1.3 billion remain in national warehouse
Summary
The Office of the Ombudsman received a fresh complaint on March 31 accusing Health Secretary Herbosa and sixteen senior officials of allowing roughly 1.5 billion pesos of medicines and vaccines to become dead stock.
The complainants, a group of self‑identified Department of Health personnel, allege that high‑value contracts for family‑planning and mental‑health commodities resulted in large inventories that were never dispatched to regional units. An inventory report shows P1.3 billion worth of vaccines—including doses for tuberculosis, measles, mumps and rubella—still sitting in the national warehouse as of January 22, 2026, with some batches already past their expiration dates between December 2025 and March 2026.
The filing cites specific violations such as serious dishonesty, grave misconduct and conduct prejudicial to public service, and calls for the preventive suspension of all respondents to stop further alleged abuse of authority. The group also criticizes the Disease Prevention and Control Bureau for failing to identify bottlenecks or operational risks despite its reorganized mandate.
If upheld, the allegations could trigger criminal prosecution, administrative penalties, and a shake‑up of the DOH’s supply‑chain governance, raising concerns about vaccine availability and eroding public trust in the health system.
Comments
Want to join the conversation?
Loading comments...